At close: December 20 at 4:00:02 PM EST
Pre-Market: 8:04:36 AM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
41,201.00
77,691.00
89,205.00
38,282.00
Total Liabilities Net Minority Interest
28,456.00
29,977.00
25,068.00
61,844.00
Total Equity Gross Minority Interest
12,745.00
47,714.00
64,137.00
-23,562.00
Total Capitalization
25,128.00
68,564.00
64,697.00
-23,079.00
Common Stock Equity
12,745.00
47,714.00
64,137.00
-23,562.00
Capital Lease Obligations
1,486.00
1,950.00
--
--
Net Tangible Assets
12,745.00
47,714.00
64,137.00
-23,562.00
Working Capital
22,613.00
66,330.00
79,583.00
30,433.00
Invested Capital
34,021.00
68,564.00
64,697.00
-22,616.00
Tangible Book Value
12,745.00
47,714.00
64,137.00
-23,562.00
Total Debt
22,762.00
22,800.00
560.00
946.00
Share Issued
29,213.63
29,042.42
28,689.84
24,796.68
Ordinary Shares Number
29,091.02
28,919.81
28,689.84
24,796.68
Treasury Shares Number
122.61
122.61
--
--
12/31/2020 - 7/27/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BPTH Bio-Path Holdings, Inc.
1.2600
-15.44%
PRTG Portage Biotech Inc.
5.96
+1.88%
PBM Psyence Biomedical Ltd.
3.1800
+29.27%
CGTX Cognition Therapeutics, Inc.
0.6301
-0.62%
PLRZ Polyrizon Ltd.
1.5700
-32.62%
ELAB Elevai Labs Inc.
2.5600
+8.94%
HUMA Humacyte, Inc.
4.6400
+34.10%
CERO CERo Therapeutics Holdings, Inc.
0.0561
+3.89%
TNXP Tonix Pharmaceuticals Holding Corp.
0.6116
+7.30%
MESO Mesoblast Limited
14.63
-12.71%